Use of bone mesenchymal stem cells to treat rats with acute liver failure

Genetics and Molecular Research

Volumn 13, Issue 3, 2014, Pages 6962-6980

  Yuan, S F ^a   Jiang, T ^b   Sun, L H ^a   Zheng, R J ^a   Cao, G Q ^a   Ahat, N Z ^c   Zhang, Y X ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b Key Laboratory of Xinjiang Medical Animal Model Research   (China)

^c XINJIANG UNIVERSITY   (China)

Author keywords

Acute liver failure; Bone mesenchymal stem cells; Cell transplantation; Portal venous transplantation; Stromal cell derived factor 1 alpha; Vascular endothelial growth factor

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BETA1 INTEGRIN; GALACTOSAMINE; STROMAL CELL DERIVED FACTOR 1ALPHA; THY 1 ANTIGEN; VASCULOTROPIN;

ACUTE LIVER FAILURE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DEATH; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; DENATURATION; HISTOPATHOLOGY; IMMUNOFLUORESCENCE TEST; IN SITU HYBRIDIZATION; IN VIVO STUDY; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER REGENERATION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; STEM CELL TRANSPLANTATION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BLOOD; BONE MARROW CELL; CYTOLOGY; LIVER FAILURE, ACUTE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PATHOPHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

RATTUS;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BONE MARROW CELLS; LIVER FAILURE, ACUTE; LIVER FUNCTION TESTS; LIVER REGENERATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 84907168744     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.April.30.10     Document Type: Article

References (28)

1. Alison MR, Islam S and Lim S (2009). Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly. J. Pathol. 217: 282-298.
2. Alon T, Hemo I, Itin A, Pe'er J, et al. (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1: 1024-1028.
3. Askari AT, Unzek S, Popovic ZB, Goldman CK, et al. (2003). Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362: 697-703.
4. Bhakta S, Hong P and Koc O (2006). The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Cardiovasc. Revasc. Med. 7: 19-24.
5. Burns JM, Summers BC, Wang Y, Melikian A, et al. (2006). A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203: 2201-2213.
6. Cho KA, Ju SY, Cho SJ, Jung YJ, et al. (2009). Mesenchymal stem cells showed the highest potential for the regeneration of injured liver tissue compared with other subpopulations of the bone marrow. Cell Biol. Int. 33: 772-777.
7. Enns GM and Millan MT (2008). Cell-based therapies for metabolic liver disease. Mol. Genet. Metab. 95: 3-10.
8. Gao E, Lei YH, Shang X, Huang ZM, et al. (2010). A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ. Res. 107: 1445-1453.
9. Huang PH, Chen YH, Tsai HY, Chen JS, et al. (2010). Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arterioscler. Thromb. Vasc. Biol. 30: 869-877.
10. Jung KH, Shin HP, Lee S, Lim YJ, et al. (2009). Effect of human umbilical cord blood-derived mesenchymal stem cells in a cirrhotic rat model. Liver Int. 29: 898-909.
11. Kaplowitz N (2000). Mechanisms of liver cell injury. J. Hepatol. 32: 39-47.
12. Kim WR and Kremers WK (2008). Benefits of "the benefit model" in liver transplantation. Hepatology 48: 697-698.
13. Kuang D, Zhao X, Xiao G, Ni J, et al. (2008). Stem cell factor/c-kit signaling mediated cardiac stem cell migration via activation of p38 MAPK. Basic Res. Cardiol. 103: 265-273.
14. Lee WM, Squires RH Jr, Nyberg SL, Doo E, et al. (2008). Acute liver failure: Summary of a workshop. Hepatology 47: 1401-1415.
15. Liu F, Liu ZD, Wu N, Cong X, et al. (2009). Transplanted endothelial progenitor cells ameliorate carbon tetrachloride-induced liver cirrhosis in rats. Liver Transpl. 15: 1092-1100.
16. Los M, Voest EE and Borel Rinkes IH (2005). VEGF as a target of therapy in gastrointestinal oncology. Dig. Surg. 22: 282-293.
17. Lysy PA, Campard D, Smets F, Najimi M, et al. (2008). Stem cells for liver tissue repair: current knowledge and perspectives. World J. Gastroenterol. 14: 864-875.
18. Ma J, Ge J, Zhang S, Sun A, et al. (2005). Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res. Cardiol. 100: 217-223.
19. Masson S, Harrison DJ, Plevris JN and Newsome PN (2004). Potential of hematopoietic stem cell therapy in hepatology: a critical review. Stem Cells 22: 897-907.
20. Muraca M (2011). Evolving concepts in cell therapy of liver disease and current clinical perspectives. Dig. Liver Dis. 43: 180-187.
21. Oertel M and Shafritz DA (2008). Stem cells, cell transplantation and liver repopulation. Biochim. Biophys. Acta 1782: 61-74.
22. Rust C and Gores GJ (2000). Apoptosis and liver disease. Am. J. Med. 108: 567-574.
23. Sato Y, Araki H, Kato J, Nakamura K, et al. (2005). Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 106: 756-763.
24. Stutchfield BM, Forbes SJ and Wigmore SJ (2010). Prospects for stem cell transplantation in the treatment of hepatic disease. Liver Transpl. 16: 827-836.
25. Takamiya M, Haider KH and Ashraf M (2011). Identification and characterization of a novel multipotent sub-population of Sca-1(+) cardiac progenitor cells for myocardial regeneration. PLoS One 6: e25265.
26. Tang YL, Shen L, Qian K and Phillips MI (2007). A novel two-step procedure to expand cardiac Sca-1+ cells clonally. Biochem. Biophys. Res. Commun. 359: 877-883.
27. Thelen M and Thelen S (2008). CXCR7, CXCR4 and CXCL12: an eccentric trio? J. Neuroimmunol. 198: 9-13.
28. Wang H, Yin Y, Li W, Zhao X, et al. (2012). Over-expression of PDGFR-beta promotes PDGF-induced proliferation, migration, and angiogenesis of EPCs through PI3K/Akt signaling pathway. PLoS One 7: e30503.